This is consistent with studies showing increased ACE2 affinity and infection capability of SARS‐CoV‐2 variants,[54, 55, 56, 57] and increased affinity and neutralization of variants with ACE2 decoys.[66, 67, 68] These results clearly indicate that our multimerized sACE2 decoys are powerful tools against SARS‐CoV‐2 variants. Here, ACE2 is linked to infection.